For more information visit us at www.nucro-technics.com
Since 1970, Nucro-Technics has provided pre-clinical toxicology, pharmacokinetic, bioanalytical method development/validation, genetic toxicology, and biomarker analysis services to the pharmaceutical, medical device, and biotech industries. Responsiveness, scientific knowledge, experience, and strong, enduring sponsor relationships have branded us as a high-performance CRO. Nucro-Technics has been inspected by the FDA, Health Canada, the SCC for compliance to GLP, and is accredited to both AAALAC and the CCAC.
We enjoy working in a consultative capacity with our clients (without the associated consulting fees) as we see this as a value-add to our main business of conducting non-clinical studies. Nucro-Technics has a long history of providing GLP and GMP-compliant contracted research & development services to a wide array of pharmaceutical and biotech firms. We pride ourselves on functioning as a single source for companies that need to fulfill regulatory testing requirements to bring their products through to the next phase of drug development.